Listen: Robert Califf on how drugs get approved, plus the nascent revolution in obesity
What keeps the FDA commissioner up at night? How will Ozempic change the world? And what’s behind WeightWatchers’ pivot?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. FDA Commissioner Robert Califf joins to discuss his first year on the job, the future of drug approvals, and how Duke basketball will do without Coach K. Then STAT’s Elaine Chen explains how powerful new weight loss medicines are reshaping medicine, the drug industry, and the society at large. We also discuss the latest news in the life sciences, including the results of a new Alzheimer’s disease study and a potential breakthrough in cardiovascular medicine.
